New figures show the extent to which Australians are using insulin to treat their diabetes.
Figures from the Australian Institute of Health and Welfare (AIHW) reveal that in 2015, 28,775 Australians treated diabetes with insulin.
Of this number, almost two thirds (63 per cent) had type 2 diabetes.
Almost all (92 per cent) of new cases of insulin-treated type 2 diabetes occurred in people aged over 40.
Type 2 Diabetes is one of Australia’s fastest growing diseases. It’s estimated that over 500 thousand Australians don’t know they have the condition.
Commenting on the figures, Philip Owens from Omni Innovation said:
“Type 2 diabetes is often referred to as the silent killer.
“It’s one of the biggest public health issues facing Australia today.
“As a nation, we have to stop or slow the progression of the pathway to type 2 diabetes.
“We know that changing lifestyle factors like diet and exercise definitely help – but that’s not always possible in every case.”
Omni Innovation is a Melbourne-based company that specialises in Medical Nutrition.
Its patented nutrition concept for type 2 diabetes is on the market as Faulding GlucoControl. It’s a drink that is taken before meals to reduce the Glyceamic Index (GI) of food and drink and controls the spikes in blood glucose which, over time, cause damage associated with this disease.
“Having the pre-meal drink as part of lifestyle choices can delay or stop such progression.”
“In a recent study, the once a day drink was found to reduce the spikes in blood sugar levels after a high GI meal and improve overall glycaemic control (HbA1c) in the long term.”
“The likelihood that type 2 diabetes impacts you, or someone you love, is greater than ever. Diabetes cannot be cured but with proper management, we can reduce the severity and likelihood of its serious consequences.”